MARZ, KEITH – Trademark Portfolio
Entity Type: 01
MARZ, KEITH holds 32 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. The portfolio also extends into Class 25 (Clothing) across 5 Nice Classification classes. Currently, 11 trademarks are registered and 3 are pending. Notable registered marks include CROSS, CUFFONS, DR. SLIM, GOT FAT?, and SKINLIFT. The owner is based in VAN NUYS, CA.
6077 VAN NUYS BLVD.
VAN NUYS, CA 91401
Showing of trademarks Trademarks
Trademark Classifications
MARZ, KEITH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does MARZ, KEITH have?
MARZ, KEITH has 32 U.S. trademarks filed with the USPTO. Of these, 11 registered, 3 pending, 10 abandoned, 8 cancelled.
What trademark classes does MARZ, KEITH file in?
MARZ, KEITH files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 20 (Furniture). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MARZ, KEITH's most well-known trademarks?
MARZ, KEITH's registered trademark portfolio includes well-known marks such as CROSS, CUFFONS, DR. SLIM, GOT FAT?, and SKINLIFT. These are among 11 currently registered trademarks in the portfolio.
What is MARZ, KEITH's trademark registration success rate?
MARZ, KEITH has a 38% trademark registration rate, with 11 out of 29 resolved applications resulting in successful registration. Currently, 3 applications are pending review.